Private company
SomaLogic, Inc.
American commercial physical and biological research services company.
Last updated Oct 18, 2026.
Overview
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2022
Where the money goes
Where each dollar of revenue went, fiscal 2022
- Research and development32¢$73.4M
- Selling, general and admin68¢$156.6M
- Income tax0¢$717.0K
Out of $97.7M in revenue.3 The company lost money this year.
Financial statements
| Fiscal year | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| Revenue | $55.9M4 | $81.6M3 | $97.7M3 | |
| Research and development | $30.7M4 | $43.5M3 | $73.4M3 | |
| Selling, general and admin | $36.9M4 | $78.0M3 | $156.6M3 | |
| Operating income | -$34.4M4 | -$73.3M3 | -$175.8M3 | |
| Interest | $18.3M4 | $1.3M3 | $03 | |
| Income tax | $23.0K4 | $38.0K3 | -$717.0K3 | |
| Net income | -$53.0M4 | -$87.5M3 | -$109.2M3 | |
| Earnings per share | -$0.814 | -$0.643 | -$0.593 | |
| Earnings per share (diluted) | -$0.814 | -$0.643 | -$0.593 |
| Fiscal year | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| Cash | $14.3M4 | $164.9M4 | $439.5M3 | $421.8M3 |
| Current assets | $232.0M4 | $691.6M3 | $581.7M3 | |
| Total assets | $242.3M4 | $706.1M3 | $647.4M3 | |
| Current liabilities | $17.8M4 | $29.3M3 | $43.3M3 | |
| Long-term debt | $32.3M4 | $04 | ||
| Total liabilities | $56.4M4 | $94.1M3 | $84.8M3 | |
| Shareholders’ equity | $20.4M4 | $185.9M3 | $612.0M3 | $562.6M3 |
| Shares outstanding | 114.3M shares4 | 181.6M shares3 | 187.6M shares3 |
Leadership
Who has led SomaLogic, Inc., and when. Pick a name to see everywhere that person has worked.
Chief executive
Chair
President
Chief financial officer
Chief operating officer
- Chief executive officerAdam Taich Apr 7, 2023 to Jan 9, 20248
- Chief executive officerEli Casdin Feb 22, 2021 to Feb 22, 20219
- Chief executive officerRoy Smythe Sep 10, 2021 to Sep 19, 202210
- ChairTroy Cox Oct 18, 2022 to Mar 22, 202311
- PresidentMelody Harris Sep 10, 2021 to Mar 3, 202212
- Chief financial officerEliot M. Lurier Jun 15, 2023 to Jun 15, 202313
- Chief financial officerBrian Emes Feb 22, 2021 to Feb 22, 202114
- Chief financial officerShaun M. Blakeman Sep 10, 2021 to Mar 22, 202315
- Chief operating officerMelody Harris Sep 10, 2021 to Mar 3, 202212
Board members and other officers (18)
- Chief People OfficerAlison Marie Roelke Aug 18, 2023 to Jan 9, 202416
- Chief Strategy OfficerShaun Rodriguez Feb 22, 2021 to Feb 22, 202117
- SVPFAmy Graves Sep 10, 2021 to Mar 22, 202318
- Board memberJason Ryan Apr 7, 2023 to Jan 9, 202419
- Board memberKathy L. Hibbs Apr 7, 2023 to Jan 9, 202420
- Board memberThomas D. Carey Apr 7, 2023 to Jan 9, 202421
- Board memberTycho Peterson Jun 14, 2023 to Jan 9, 202422
- Board memberEli Casdin Feb 22, 2021 to Jan 9, 20249
- Board memberJason Kelly Feb 22, 2021 to Feb 22, 202123
- Board memberKevin T. Conroy Feb 22, 2021 to Sep 3, 202124
- Board memberStephen Quake Feb 22, 2021 to Mar 3, 202225
- Board memberTroy Cox Feb 22, 2021 to Jan 9, 202426
- Board memberAnne H. Margulies Sep 10, 2021 to Jan 9, 202427
- Board memberRichard A. Post Sep 10, 2021 to Jan 9, 202428
- Board memberRobert Barchi Sep 10, 2021 to Jan 9, 202429
- Board memberRoy Smythe Sep 10, 2021 to Sep 19, 202210
- Board memberTed D. Meisel Sep 10, 2021 to Mar 22, 202330
- General counselRuben Gutierrez Sep 10, 2021 to Jan 9, 202431
Former names
- CM Life Sciences II Inc.Dec 31, 2020 to Sep 1, 20212
Timeline
Filings
198 filings to the SEC since October 2021: 2 annual reports, 7 quarterly reports, 43 major events, 73 insider forms, 7 large holders, 66 other. The latest 20:
- Jan 10, 2025SCHEDULE 13G/A EDGAR
- Jan 29, 2024SC 13G/A EDGAR
- Jan 16, 202415-12G EDGAR
- Jan 11, 2024EFFECT EDGAR
- Jan 11, 2024EFFECT EDGAR
- Jan 9, 20244 FORM 4 SUBMISSION EDGAR
- Jan 9, 20244 FORM 4 SUBMISSION EDGAR
- Jan 9, 20244 FORM 4 SUBMISSION EDGAR
- Jan 9, 20244 FORM 4 SUBMISSION EDGAR
- Jan 9, 20244 FORM 4 SUBMISSION EDGAR
- Jan 9, 20244 FORM 4 SUBMISSION EDGAR
- Jan 9, 20244 FORM 4 SUBMISSION EDGAR
- Jan 9, 20244 FORM 4 SUBMISSION EDGAR
- Jan 9, 20244 FORM 4 SUBMISSION EDGAR
- Jan 9, 20244 FORM 4 SUBMISSION EDGAR
- Jan 9, 20244 FORM 4 SUBMISSION EDGAR
- Jan 9, 20244 FORM 4 SUBMISSION EDGAR
- Jan 9, 20244 FORM 4 SUBMISSION EDGAR
- Jan 9, 2024SC 13D/A EDGAR
- Jan 5, 2024POS AM EDGAR
The 198 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last three years, summarized. The full record is on SEC EDGAR.
Insider trades and holders
Large holders
Investors who own more than 5% must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively. 7 such filings since October 2021:
- Jan 10, 2025SCHEDULE 13G/A
- Jan 29, 2024SC 13G/A
- Jan 9, 2024SC 13D/A
- Feb 14, 2023SC 13G/A
- Dec 14, 2022SC 13D/A
- Feb 11, 2022SC 13G
- Oct 8, 2021SC 13G
From Forms 4 and Schedules 13D and 13G filed with the SEC.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARSomaLogic, Inc. filings on SEC EDGAR
- 2SEC EDGARSomaLogic, Inc. filings on SEC EDGAR
- 3SEC EDGARSomaLogic, Inc. 10-K for fiscal 2022
- 4SEC EDGARSomaLogic, Inc. 10-K for fiscal 2020
- 5SEC EDGARSomaLogic, Inc. 10-Q for fiscal 2023
- 6SEC EDGARSomaLogic, Inc. 10-Q for fiscal 2023
- 7SEC EDGARSomaLogic, Inc. 10-Q for fiscal 2023
- 8SEC EDGARAdam Taich, Chief executive officer
- 9SEC EDGAREli Casdin, Chief executive officer
- 10SEC EDGARRoy Smythe, Chief executive officer
- 11SEC EDGARTroy Cox, Chair
- 12SEC EDGARMelody Harris, President
- 13
- 14SEC EDGARBrian Emes, Chief financial officer
- 15
- 16
- 17
- 18SEC EDGARAmy Graves, SVPF
- 19SEC EDGARJason Ryan, Board member
- 20SEC EDGARKathy L. Hibbs, Board member
- 21SEC EDGARThomas D. Carey, Board member
- 22SEC EDGARTycho Peterson, Board member
- 23SEC EDGARJason Kelly, Board member
- 24SEC EDGARKevin T. Conroy, Board member
- 25SEC EDGARStephen Quake, Board member
- 26SEC EDGARTroy Cox, Board member
- 27SEC EDGARAnne H. Margulies, Board member
- 28SEC EDGARRichard A. Post, Board member
- 29SEC EDGARRobert Barchi, Board member
- 30SEC EDGARTed D. Meisel, Board member
- 31SEC EDGARRuben Gutierrez, General counsel